MINNEAPOLIS--(BUSINESS WIRE)--Healthcare experts from VigiLanz, a software and services firm delivering healthcare intelligence to more than 300 hospitals, addressed hospital leaders from across the nation on the topic of ”Bending the Outcome Curve in the Fight Against Sepsis with Real-Time and Predictive Clinical Intelligence” at the recent Becker’s Hospital Review 7th Annual Meeting in Chicago. VigiLanz also hosted a Becker’s webinar on the topic, with more than 230 healthcare professionals attending.
The Becker’s Hospital Review conference is a premier event in healthcare drawing more than 1500 executives and clinicians from hospitals including the Mayo Clinic, Cleveland Clinic, Advocate Healthcare, University of Chicago Medical Center and Phoenix Children’s Hospital. Nearly 90 hospital CEOs, CFOs and CIOs, along with leading health technology innovators, led educational sessions.
Webinar Showcases Improvements in Patient Outcomes from Real-Time Intelligence
VigiLanz CTO Adam Klass and Chief Data Scientist Bart Abbas, Ph.D., addressed more than 230 webinar participants on key ways healthcare systems can leverage the value of the electronic health record (EHR) systems through a SaaS-based enterprise intelligence resources platform (EIR). The session focused on how this integrated approach can enable health delivery organizations to turn clinical data into meaningful, actionable intelligence. Results from predictive analytics pilots in the early identification of patients at risk for sepsis were also shared.
Real-Time Data Insights Link Directly to Clinical Outcomes
In the conference presentation, VigiLanz CEO Dr. David Goldsteen observed that hospitals struggle to glean actionable information from an ever-increasing deluge of data. “Even with significant investments in the electronic medical record (EHR) systems, today’s clinicians are still in need of easier access to the insights that can help them improve care delivery,” he said. “Data and analytics – when leveraged in real-time – can help bridge this gap, enabling improved decision making and predictions that link directly to clinical, operational and financial outcomes.”
For example, real-time clinical and predictive intelligence can save lives and reduce costs related to infectious diseases such as sepsis, he noted. Sepsis alone affects more than one million patients annually, causing 280,000 deaths and accounting for 40 percent of ICU spending and nearly $29 billion in healthcare costs.
Dr. Goldsteen continued, “Today’s health professionals must leverage technology to embrace the care continuum. As reimbursement is linked to value, clinical outcomes and data are more entwined with the revenue cycle. What’s needed is ‘anytime’ intelligence to power better decisions for individual patient care and the health of populations.”
About VigiLanz
VigiLanz Corporation (www.vigilanzcorp.com) is a privately held, rapidly growing provider of SaaS health care intelligence and predictive analytics. The firm is focused on aggregating disparate EHR transactional workflow and documentation data across health systems to identify real-time clinical issues that avoid or minimize harm, optimize clinical outcomes and support preventive care along the entire health system continuum. The company was founded in 2001. VigiLanz supports a large and growing community of hospital CMOs, CMIOs, CIOs, quality teams, infectious disease and control specialists, pharmacists, and other clinicians dedicated to real-time inpatient and outpatient care. VigiLanz is shaping the emerging era of real-time health care by delivering enterprise intelligence technology and services that improve clinical outcomes, patient care and operational effectiveness.
